Bivigam Alternatives Compared
| Bivigam (immune globulin intravenous) | Hizentra (immune globulin subcutaneous) | Gammagard Liquid (immune globulin intravenous and subcutaneous) |
|
|---|
| Bivigam (immune globulin intravenous) | Hizentra (immune globulin subcutaneous) | Gammagard Liquid (immune globulin intravenous and subcutaneous) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Primary Immunodeficiency Syndrome. Bivigam may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome. Hizentra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Multifocal Motor Neuropathy. Gammagard Liquid may also be used for purposes not listed in... View more |
||||||||||||||||||||||||
| More about Bivigam (immune globulin intravenous) | More about Hizentra (immune globulin subcutaneous) | More about Gammagard Liquid (immune globulin intravenous and subcutaneous) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Hizentra has an average rating of 6.7 out of 10 from a total of 33 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 26% reported a negative effect. |
Gammagard Liquid has an average rating of 7.6 out of 10 from a total of 7 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Bivigam side effects |
View all Hizentra side effects |
View all Gammagard Liquid side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Bivigam prices |
View all Hizentra prices |
View all Gammagard Liquid prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other immune globulin intravenous brands include: Alyglo, Asceniv, Carimune NF, Flebogamma, Gammagard S/D, Gammaplex, Octagam, Panzyga, Privigen, Yimmugo View more | Other immune globulin subcutaneous brands include: Cutaquig, Cuvitru, Xembify | Other immune globulin intravenous and subcutaneous brands include: Gammagard Liquid ERC, Gammaked, Gamunex-C | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
576 hours |
564 hours |
857.76 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 107 drugs are known to interact with Bivigam:
|
A total of 23 drugs are known to interact with Hizentra:
|
A total of 107 drugs are known to interact with Gammagard Liquid:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.